Skip to main content
Erschienen in:

06.11.2019 | Cancer-Associated Voiding Dysfunction (S Elliott and J Pariser, Section Editor)

Rectourethral Fistula—Review of Current Practices, Developments, and Outcomes

verfasst von: Kirtishri Mishra, Nathan Y. Hoy, Hadley M. Wood, Kenneth W. Angermeier

Erschienen in: Current Bladder Dysfunction Reports | Ausgabe 4/2019

Einloggen, um Zugang zu erhalten

Abstract

Purpose of Review

Rectourethral fistula (RUF) is an uncommon pathology associated with a significant deterioration in quality of life. It can result from a variety of etiologies and frequently occurs in medically complex patients. Due to the involvement of both the urinary and fecal systems, there are a number of treatment considerations. The literature surrounding management of this condition is quite varied due to these factors.

Recent Findings

Recent literature on the field consists primarily of single institution case series, though there is a recently published multi-center cohort study with a relatively larger sample size. There is no clear surgical technique that appears to be superior. Transperineal repair is the most commonly described approach. In the properly selected patient, RUF repair results in success rates approaching 85–90%, though the definition of success is not standardized in the literature, and success rates are lower in patients post radiation or ablative therapy.

Summary

This review highlights contemporary developments in the RUF literature, and provides an overview of important work-up and management considerations. Overall, there is no standardized protocol for management of RUF. Every case presents a unique challenge as a result of the RUF etiology, anatomical considerations, varying degrees of involvement of the genitourinary and gastrointestinal tracts, and patient comorbidities. Urologists must ultimately understand the disease process and utilize techniques that they feel most comfortable with.
Literatur
1.
Zurück zum Zitat Choi JH, Jeon BG, Choi S, Han EC, Ha H, Oh H, et al. Rectourethral fistula: systemic review of and experiences with various surgical treatment. Methods. 2013;30:35–41. Choi JH, Jeon BG, Choi S, Han EC, Ha H, Oh H, et al. Rectourethral fistula: systemic review of and experiences with various surgical treatment. Methods. 2013;30:35–41.
2.
Zurück zum Zitat Chen S, Gao R, Li H, Wang K. Management of acquired rectourethral fistulas in adults 2018;5:149-154. Chen S, Gao R, Li H, Wang K. Management of acquired rectourethral fistulas in adults 2018;5:149-154.
3.
Zurück zum Zitat Faris SF, Milam DF, Dmochowski RR, Kaufman MR. Urinary diversions after radiation for prostate cancer: indications and treatment. Urology. 2014;84:702–6.CrossRef Faris SF, Milam DF, Dmochowski RR, Kaufman MR. Urinary diversions after radiation for prostate cancer: indications and treatment. Urology. 2014;84:702–6.CrossRef
4.
Zurück zum Zitat Bukowski TP, Chakrabarty A, Powell IJ, Frontera R, Perlmutter AD, Montie JE. Acquired rectourethral fistula: methods of repair. J Urol. 1995;153:730–3.CrossRef Bukowski TP, Chakrabarty A, Powell IJ, Frontera R, Perlmutter AD, Montie JE. Acquired rectourethral fistula: methods of repair. J Urol. 1995;153:730–3.CrossRef
5.
Zurück zum Zitat Venkatesan K, Zacharakis E, Andrich DE, Mundy AR. Conservative management of urorectal fistulae. Urology. 2013;81:1352–6.CrossRef Venkatesan K, Zacharakis E, Andrich DE, Mundy AR. Conservative management of urorectal fistulae. Urology. 2013;81:1352–6.CrossRef
6.
Zurück zum Zitat Singla N, Morey AF. Rectourethral fistula reconstruction in elderly patients. Curr Opin Urol. 2016;26:171–6.CrossRef Singla N, Morey AF. Rectourethral fistula reconstruction in elderly patients. Curr Opin Urol. 2016;26:171–6.CrossRef
7.
Zurück zum Zitat •• Hechenbleikner EM, Buckley JC, Wick EC. Acquired rectourethral fistulas in adults: a systematic review of surgical repair techniques and outcomes 2013;56;374-383. A comprehensive systematic review of the various prominent studies performed prior to 2013. •• Hechenbleikner EM, Buckley JC, Wick EC. Acquired rectourethral fistulas in adults: a systematic review of surgical repair techniques and outcomes 2013;56;374-383. A comprehensive systematic review of the various prominent studies performed prior to 2013.
8.
Zurück zum Zitat Munoz M, Nelson H, Harrington J, Tsiotos G, Devine R, Engen D. Management of acquired rectourinary fistulas: outcome according to cause. Dis Colon Rectum. 1998;41:1230–8.CrossRef Munoz M, Nelson H, Harrington J, Tsiotos G, Devine R, Engen D. Management of acquired rectourinary fistulas: outcome according to cause. Dis Colon Rectum. 1998;41:1230–8.CrossRef
9.
Zurück zum Zitat Scozzari G, Arezzo A, Morino M. Enterovesical fistulas: diagnosis and management. Tech Coloproctol. 2010;14:293–300.CrossRef Scozzari G, Arezzo A, Morino M. Enterovesical fistulas: diagnosis and management. Tech Coloproctol. 2010;14:293–300.CrossRef
10.
Zurück zum Zitat Golabek T, Szymanska A, Szopinski T, Bukowczan J, Furmanek M, Powroznik J, Chlosta P. Enterovesical fistulae: aetiology, imaging, and management 2013;2013:617967. Golabek T, Szymanska A, Szopinski T, Bukowczan J, Furmanek M, Powroznik J, Chlosta P. Enterovesical fistulae: aetiology, imaging, and management 2013;2013:617967.
11.
Zurück zum Zitat Keller DS, Aboseif SR, Lesser T, Abbass MA, Tsay AT, Abbas MA. Algorithm-based multidisciplinary treatment approach for rectourethral fistula. Int J Color Dis. 2015;30:631–8.CrossRef Keller DS, Aboseif SR, Lesser T, Abbass MA, Tsay AT, Abbas MA. Algorithm-based multidisciplinary treatment approach for rectourethral fistula. Int J Color Dis. 2015;30:631–8.CrossRef
12.
Zurück zum Zitat Mandel P, Linnemannstöns A, Chun F, Schlomm T, Pompe R, Budäus L, et al. Incidence, risk factors, management, and complications of rectal injuries during radical prostatectomy. Eur Urol Focus. 2018;4:554–7.CrossRef Mandel P, Linnemannstöns A, Chun F, Schlomm T, Pompe R, Budäus L, et al. Incidence, risk factors, management, and complications of rectal injuries during radical prostatectomy. Eur Urol Focus. 2018;4:554–7.CrossRef
13.
Zurück zum Zitat Barashi NS, Pearce SM, Cohen AJ, Pariser JJ, Packiam VT, Eggener SE. Incidence, risk factors, and outcomes for rectal injury during radical prostatectomy: a population-based study. Eur Urol Oncol. 2018;1:501–6.CrossRef Barashi NS, Pearce SM, Cohen AJ, Pariser JJ, Packiam VT, Eggener SE. Incidence, risk factors, and outcomes for rectal injury during radical prostatectomy: a population-based study. Eur Urol Oncol. 2018;1:501–6.CrossRef
14.
Zurück zum Zitat Shin PR, Foley E, Steers WD. Surgical management of rectourinary fistulae1. J Am Coll Surg. 2000;191:547–53.CrossRef Shin PR, Foley E, Steers WD. Surgical management of rectourinary fistulae1. J Am Coll Surg. 2000;191:547–53.CrossRef
15.
Zurück zum Zitat Zinman L. The management of the complex recto-urethral fistula. BJU Int. 2004;94:1212–3.CrossRef Zinman L. The management of the complex recto-urethral fistula. BJU Int. 2004;94:1212–3.CrossRef
16.
Zurück zum Zitat •• Martini A, Gandaglia G, Nicita G, Montorsi F. A novel classification proposal for rectourethral fistulas after primary treatment of prostate cancer. Eur Urol Oncol. 2018;1:510–1 New classification for RUF.CrossRef •• Martini A, Gandaglia G, Nicita G, Montorsi F. A novel classification proposal for rectourethral fistulas after primary treatment of prostate cancer. Eur Urol Oncol. 2018;1:510–1 New classification for RUF.CrossRef
17.
Zurück zum Zitat •• Thomas C, Jones J, Jager W, Hampel C, Thuroff JW, Gillitzer R. Incidence, clinical symptoms and management of rectourethral fistulas after radical prostatectomy. J Urol. 2010;183:608–12 One of the largest series evaluating the risk of RUF after radical prostatectomy.CrossRef •• Thomas C, Jones J, Jager W, Hampel C, Thuroff JW, Gillitzer R. Incidence, clinical symptoms and management of rectourethral fistulas after radical prostatectomy. J Urol. 2010;183:608–12 One of the largest series evaluating the risk of RUF after radical prostatectomy.CrossRef
18.
Zurück zum Zitat Lance RS, Freidrichs PA, Kane C, Powell CR, Pulos E, Moul JW, et al. A comparison of radical retropubic with perineal prostatectomy for localized prostate cancer within the Uniformed Services Urology Research Group. BJU Int. 2001;87:61–5.CrossRef Lance RS, Freidrichs PA, Kane C, Powell CR, Pulos E, Moul JW, et al. A comparison of radical retropubic with perineal prostatectomy for localized prostate cancer within the Uniformed Services Urology Research Group. BJU Int. 2001;87:61–5.CrossRef
19.
Zurück zum Zitat • Wedmid A, Mendoza P, Sharma S, Hastings RL, Monahan KP, Walicki M, et al. Rectal Injury During Robot-Assisted Radical Prostatectomy: Incidence and Management. J Urol. 2011;186:1928–33 One of the major studies looking at the risk of RUF after RALP.CrossRef • Wedmid A, Mendoza P, Sharma S, Hastings RL, Monahan KP, Walicki M, et al. Rectal Injury During Robot-Assisted Radical Prostatectomy: Incidence and Management. J Urol. 2011;186:1928–33 One of the major studies looking at the risk of RUF after RALP.CrossRef
20.
Zurück zum Zitat Harris CR, McAninch JW, Mundy AR, Zinman LN, Jordan GH, Andrich D, et al. Rectourethral Fistulas Secondary to Prostate Cancer Treatment: Management and outcomes from a multi-institutional combined experience. J Urol. 2017;197:191–4.CrossRef Harris CR, McAninch JW, Mundy AR, Zinman LN, Jordan GH, Andrich D, et al. Rectourethral Fistulas Secondary to Prostate Cancer Treatment: Management and outcomes from a multi-institutional combined experience. J Urol. 2017;197:191–4.CrossRef
21.
Zurück zum Zitat Evans LA, Ferguson KH, Foley JP, Rozanski TA, Morey AF. Fibrin sealant for the management of genitourinary injuries, fistulas and surgical complications. J Urol. 2003;169:1360–2.CrossRef Evans LA, Ferguson KH, Foley JP, Rozanski TA, Morey AF. Fibrin sealant for the management of genitourinary injuries, fistulas and surgical complications. J Urol. 2003;169:1360–2.CrossRef
22.
Zurück zum Zitat Nicita G, Villari D, Caroassai Grisanti S, Marzocco M, Li Marzi V, Martini A. Minimally invasive transanal repair of rectourethral fistulas. Eur Urol. 2017;71:133–8.CrossRef Nicita G, Villari D, Caroassai Grisanti S, Marzocco M, Li Marzi V, Martini A. Minimally invasive transanal repair of rectourethral fistulas. Eur Urol. 2017;71:133–8.CrossRef
23.
Zurück zum Zitat Siegel R, DeSantis C, Virgo K, Stein K, Mariotto A, Smith T, et al. Cancer treatment and survivorship statistics, 2012. CA Cancer J Clin. 2012;62:220–41.CrossRef Siegel R, DeSantis C, Virgo K, Stein K, Mariotto A, Smith T, et al. Cancer treatment and survivorship statistics, 2012. CA Cancer J Clin. 2012;62:220–41.CrossRef
24.
Zurück zum Zitat Chrouser KL, Leibovich BC, Sweat SD, Larson DW, Davis BJ, Tran NV, et al. Urinary fistulas following external beam radiation or permanent brachytherapy for the treatment of prostate cancer. J Urol. 2005;173:1953–7.CrossRef Chrouser KL, Leibovich BC, Sweat SD, Larson DW, Davis BJ, Tran NV, et al. Urinary fistulas following external beam radiation or permanent brachytherapy for the treatment of prostate cancer. J Urol. 2005;173:1953–7.CrossRef
25.
Zurück zum Zitat Davis JW, Schellhammer PF. Prostatorectal fistula 14 years following brachytherapy for prostate cancer. J Urol. 2001;165:189.CrossRef Davis JW, Schellhammer PF. Prostatorectal fistula 14 years following brachytherapy for prostate cancer. J Urol. 2001;165:189.CrossRef
26.
Zurück zum Zitat •• Lane BR, Stein DE, Remzi FH, Strong SA, Fazio VW, Angermeier KW. Management of radiotherapy induced rectourethral fistula. J Urol. 2006;175:1382–8 One of the higher quality studies evaluating the management of radiotherapy induced RUF.CrossRef •• Lane BR, Stein DE, Remzi FH, Strong SA, Fazio VW, Angermeier KW. Management of radiotherapy induced rectourethral fistula. J Urol. 2006;175:1382–8 One of the higher quality studies evaluating the management of radiotherapy induced RUF.CrossRef
27.
Zurück zum Zitat Linder BJ, Umbreit EC, Larson D, Dozois EJ, Thapa P, Elliott DS. Effect of prior radiotherapy and ablative therapy on surgical outcomes for the treatment of rectourethral fistulas. J Urol. 2013;190:1287–91.CrossRef Linder BJ, Umbreit EC, Larson D, Dozois EJ, Thapa P, Elliott DS. Effect of prior radiotherapy and ablative therapy on surgical outcomes for the treatment of rectourethral fistulas. J Urol. 2013;190:1287–91.CrossRef
28.
Zurück zum Zitat Mao Q, Luo J, Fang J, Jiang H. Management of radiation-induced rectovesical fistula in a woman using ileum: a case report and review of the literature. Medicine. 2017;96:e8553.CrossRef Mao Q, Luo J, Fang J, Jiang H. Management of radiation-induced rectovesical fistula in a woman using ileum: a case report and review of the literature. Medicine. 2017;96:e8553.CrossRef
29.
Zurück zum Zitat Martins FE, Martins NM, Pinheiro LC, Ferraz L, Xambre L, Lopes TM. Management of iatrogenic urorectal fistulae in men with pelvic cancer 2017;11:E372-E378. Martins FE, Martins NM, Pinheiro LC, Ferraz L, Xambre L, Lopes TM. Management of iatrogenic urorectal fistulae in men with pelvic cancer 2017;11:E372-E378.
30.
Zurück zum Zitat •• Mundy AR, Andrich DE. Urorectal fistulae following the treatment of prostate cancer. BJU Int. 2011;107:1298–303 Attempts to answer the question of whether tissue interposition is needed in all cases.CrossRef •• Mundy AR, Andrich DE. Urorectal fistulae following the treatment of prostate cancer. BJU Int. 2011;107:1298–303 Attempts to answer the question of whether tissue interposition is needed in all cases.CrossRef
31.
Zurück zum Zitat Samplaski MK, Wood HM, Lane BR, Remzi FH, Lucas A, Angermeier KW. Functional and quality-of-life outcomes in patients undergoing transperineal repair with gracilis muscle interposition for complex rectourethral fistula. Urology. 2011;77:736–41.CrossRef Samplaski MK, Wood HM, Lane BR, Remzi FH, Lucas A, Angermeier KW. Functional and quality-of-life outcomes in patients undergoing transperineal repair with gracilis muscle interposition for complex rectourethral fistula. Urology. 2011;77:736–41.CrossRef
32.
Zurück zum Zitat • Vanni AJ, Buckley JC, Zinman LN. Management of surgical and radiation induced rectourethral fistulas with an interposition muscle flap and selective buccal mucosal onlay graft. J Urol. 2010;184:2400–4 Robust study on perineal approach.CrossRef • Vanni AJ, Buckley JC, Zinman LN. Management of surgical and radiation induced rectourethral fistulas with an interposition muscle flap and selective buccal mucosal onlay graft. J Urol. 2010;184:2400–4 Robust study on perineal approach.CrossRef
33.
Zurück zum Zitat Voelzke BB, McAninch JW, Breyer BN, Glass AS, Garcia-Aguilar J. Transperineal management for postoperative and radiation rectourethral fistulas. J Urol. 2013;189:966–71.CrossRef Voelzke BB, McAninch JW, Breyer BN, Glass AS, Garcia-Aguilar J. Transperineal management for postoperative and radiation rectourethral fistulas. J Urol. 2013;189:966–71.CrossRef
34.
Zurück zum Zitat Kaufman DA, Zinman LN, Buckley JC, Marcello P, Browne BM, Vanni AJ. Short- and Long-term complications and outcomes of radiation and surgically induced rectourethral fistula repair with buccal mucosa graft and muscle interposition flap. Urology. 2016;98:170–5.CrossRef Kaufman DA, Zinman LN, Buckley JC, Marcello P, Browne BM, Vanni AJ. Short- and Long-term complications and outcomes of radiation and surgically induced rectourethral fistula repair with buccal mucosa graft and muscle interposition flap. Urology. 2016;98:170–5.CrossRef
35.
Zurück zum Zitat Dreznik Z, Alper D, Vishne TH, Ramadan E. Rectal flap advancement--a simple and effective approach for the treatment of rectourethral fistula. Color Dis. 2003;5:53–5.CrossRef Dreznik Z, Alper D, Vishne TH, Ramadan E. Rectal flap advancement--a simple and effective approach for the treatment of rectourethral fistula. Color Dis. 2003;5:53–5.CrossRef
36.
Zurück zum Zitat • Renschler TD, Middleton RG. 30 Years of experience with York-Mason repair of recto-urinary fistulas 2003;170:1222-1225. 30 year experience on patients with RUF repair. • Renschler TD, Middleton RG. 30 Years of experience with York-Mason repair of recto-urinary fistulas 2003;170:1222-1225. 30 year experience on patients with RUF repair.
37.
Zurück zum Zitat Selph JP, Madden-Fuentes R, Peterson AC, Webster GD, Lentz AC. Long-term artificial urinary sphincter outcomes following a prior rectourethral fistula repair. Urology. 2015;86:608–12.CrossRef Selph JP, Madden-Fuentes R, Peterson AC, Webster GD, Lentz AC. Long-term artificial urinary sphincter outcomes following a prior rectourethral fistula repair. Urology. 2015;86:608–12.CrossRef
Metadaten
Titel
Rectourethral Fistula—Review of Current Practices, Developments, and Outcomes
verfasst von
Kirtishri Mishra
Nathan Y. Hoy
Hadley M. Wood
Kenneth W. Angermeier
Publikationsdatum
06.11.2019
Verlag
Springer US
Erschienen in
Current Bladder Dysfunction Reports / Ausgabe 4/2019
Print ISSN: 1931-7212
Elektronische ISSN: 1931-7220
DOI
https://doi.org/10.1007/s11884-019-00544-5

Weitere Artikel der Ausgabe 4/2019

Treatment of Refractory Urinary Urgency, Frequency, and Incontinence in Pregnancy

  • Overactive Bladder (U Lee and S Adelstein, Section Editors)

Central Nervous System Changes in Pelvic Inflammation/Pain Patients

  • Open Access
  • Inflammatory/Infectious Bladder Disorders (MS Mourad, Section Editor)

Detrusor Underactivity and Underactive Bladder in Women: What Is New?

  • Open Access
  • Voiding Dysfunction Evaluation (B Brucker and B Peyronnet, Section Editors)

The Role of Local Hormone Replacement in Overactive Bladder

  • Overactive Bladder (U Lee and S Adelstein, Section Editors)

Classification, Characterization, and Sub-Grouping of Interstitial Cystitis

  • BPS/Interstitial Cystitis (D Castro-Diaz and Y Igawa, Section Editors)

Overactive Bladder in Diabetes Mellitus

  • Overactive Bladder (U Lee and S Adelstein, Section Editors)

Neu im Fachgebiet Urologie

Nierenzellkarzinom: Kein Nachteil durch subkutan appliziertes Nivolumab

Die subkutane Applikation von Nivolumab ist nach Daten einer Phase-3-Studie ähnlich gut wirksam wie die intravenöse: Die Pharmakokinetik ist vergleichbar, die objektive Response war in der Studie sogar leicht besser als in der Gruppe mit Infusionen.

Auf weichem Fahrradsattel ist nicht gut Kinder zeugen

Männer, die sich gern sportlich verausgaben, riskieren möglicherweise, fürs Vaterwerden nicht genug Kräfte übrig zu haben. In einer Studie fanden sich dafür zwar allenfalls schwache Anzeichen. Es gab jedoch eine Ausnahme.

Vorteile für Androgenentzug plus Androgenrezeptorblockade

Für Männer mit metastasiertem hormonsensitivem Prostata-Ca. (mHSPC), die keine Hormonchemotherapie wollen oder vertragen, ist der Androgenentzug plus Darolutamid eine Alternative: Das Progressionsrisiko wird im Vergleich zum alleinigen Androgenentzug fast halbiert.

Bei „Harnwegsinfekt“ mit Fieber an akute Prostatitis denken!

Symptome eines Harnwegsinfekts sind bei geriatrischen Patienten keinesfalls auf die leichte Schulter zu nehmen. Der Urogeriater Prof. Andreas Wiedemann von der Uni Witten/Herdecke warnt vor zwei schweren Krankheitsbildern, die immer noch häufig übersehen werden, und gibt praktische Tipps für die Diagnostik.

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.